Literature DB >> 32325398

Altered clearance of beta-amyloid from the cerebrospinal fluid following subchronic lead exposure in rats: Roles of RAGE and LRP1 in the choroid plexus.

Xiaoli Shen1, Li Xia2, Luqing Liu3, Hong Jiang4, Jonathan Shannahan5, Yansheng Du6, Wei Zheng7.   

Abstract

Formation of amyloid plaques is the hallmark of Alzheimer's disease. Our early studies show that lead (Pb) exposure in PDAPP transgenic mice increases β-amyloid (Aβ) levels in the cerebrospinal fluid (CSF) and hippocampus, leading to the formation of amyloid plaques in mouse brain. Aβ in the CSF is regulated by the blood-CSF barrier (BCB) in the choroid plexus. However, the questions as to whether and how Pb exposure affected the influx and efflux of Aβ in BCB remained unknown. This study was conducted to investigate whether Pb exposure altered the Aβ efflux in the choroid plexus from the CSF to blood, and how Pb may affect the expression and subcellular translocation of two major Aβ transporters, i.e., the receptor for advanced glycation end-products (RAGE) and the low density lipoprotein receptor protein-1 (LRP1) in the choroid plexus. Sprague-Dawley rats received daily oral gavage at doses of 0, 14 (low-dose), and 27 (high-dose) mg Pb/kg as Pb acetate, 5 d/wk, for 4 or 8 wks. At the end of Pb exposure, a solution containing Aβ40 (2.5 μg/mL) was infused to rat brain via a cannulated internal carotid artery. Subchronic Pb exposure at both dose levels significantly increased Aβ levels in the CSF and choroid plexus (p < 0.05) by ELISA. Confocal data showed that 4-wk Pb exposures prompted subcellular translocation of RAGE from the choroidal cytoplasm toward apical microvilli. Furthermore, it increased the RAGE expression in the choroid plexus by 34.1 % and 25.1 % over the controls (p < 0.05) in the low- and high- dose groups, respectfully. Subchronic Pb exposure did not significantly affect the expression of LRP1; yet the high-dose group showed LRP1 concentrated along the basal lamina. The data from the ventriculo-cisternal perfusion revealed a significantly decreased efflux of Aβ40 from the CSF to blood via the blood-CSF barrier. Incubation of freshly dissected plexus tissues with Pb in artificial CSF supported a Pb effect on increased RAGE expression. Taken together, these data suggest that Pb accumulation in the choroid plexus after subchronic exposure reduces the clearance of Aβ from the CSF to blood by the choroid plexus, which, in turn, leads to an increase of Aβ in the CSF. Interaction of Pb with RAGE and LRP1 in choroidal epithelial cells may contribute to the altered Aβ transport by the blood-CSF barrier in brain ventricles.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Beta-amyloid; Choroid plexus; LRP1; Lead; RAGE

Year:  2020        PMID: 32325398      PMCID: PMC7541561          DOI: 10.1016/j.jtemb.2020.126520

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  37 in total

1.  Inhibition by lead of production and secretion of transthyretin in the choroid plexus: its relation to thyroxine transport at blood-CSF barrier.

Authors:  W Zheng; W S Blaner; Q Zhao
Journal:  Toxicol Appl Pharmacol       Date:  1999-02-15       Impact factor: 4.219

2.  Regulation of brain copper homeostasis by the brain barrier systems: effects of Fe-overload and Fe-deficiency.

Authors:  Andrew D Monnot; Mamta Behl; Sanna Ho; Wei Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-19       Impact factor: 4.219

3.  Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice.

Authors:  Huiying Gu; Xing Wei; Andrew D Monnot; Christine V Fontanilla; Mamta Behl; Martin R Farlow; Wei Zheng; Yansheng Du
Journal:  Neurosci Lett       Date:  2010-12-16       Impact factor: 3.046

4.  Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.

Authors:  S L Yu; C K Wong; C C Szeto; E K Li; Z Cai; L S Tam
Journal:  Lupus       Date:  2014-11-18       Impact factor: 2.911

5.  Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure.

Authors:  Huiying Gu; Gregory Robison; Lan Hong; Raul Barrea; Xing Wei; Martin R Farlow; Yulia N Pushkar; Yansheng Du; Wei Zheng
Journal:  Toxicol Lett       Date:  2012-07-11       Impact factor: 4.372

6.  Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

Authors:  M Kanai; E Matsubara; K Isoe; K Urakami; K Nakashima; H Arai; H Sasaki; K Abe; T Iwatsubo; T Kosaka; M Watanabe; Y Tomidokoro; M Shizuka; K Mizushima; T Nakamura; Y Igeta; Y Ikeda; M Amari; T Kawarabayashi; K Ishiguro; Y Harigaya; K Wakabayashi; K Okamoto; S Hirai; M Shoji
Journal:  Ann Neurol       Date:  1998-07       Impact factor: 10.422

7.  RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.

Authors:  Rashid Deane; Shi Du Yan; Ram Kumar Submamaryan; Barbara LaRue; Suzana Jovanovic; Elizabeth Hogg; Deborah Welch; Lawrence Manness; Chang Lin; Jin Yu; Hong Zhu; Jorge Ghiso; Blas Frangione; Alan Stern; Ann Marie Schmidt; Don L Armstrong; Bernd Arnold; Birgit Liliensiek; Peter Nawroth; Florence Hofman; Mark Kindy; David Stern; Berislav Zlokovic
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

8.  Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent.

Authors:  Crissey L Pascale; Miles C Miller; Catherine Chiu; Matthew Boylan; Ilias N Caralopoulos; Liliana Gonzalez; Conrad E Johanson; Gerald D Silverberg
Journal:  Fluids Barriers CNS       Date:  2011-07-08

Review 9.  The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues.

Authors:  Howard Hu; Regina Shih; Stephen Rothenberg; Brian S Schwartz
Journal:  Environ Health Perspect       Date:  2006-12-22       Impact factor: 9.031

Review 10.  Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead.

Authors:  Regina A Shih; Howard Hu; Marc G Weisskopf; Brian S Schwartz
Journal:  Environ Health Perspect       Date:  2006-12-22       Impact factor: 9.031

View more
  6 in total

1.  Lead Exposure in Developmental Ages Promotes Aβ Accumulation by Disturbing Aβ Transportation in Blood-Cerebrospinal Fluid Barrier/Blood-Brain Barriers and Impairing Aβ Clearance in the Liver.

Authors:  Can-Can Zhou; Xu-Jie Wang; Zi-Chen Li; Wen-Jie Lu; Yun-Ting Zhang; Fu-Ming Shen; Dong-Jie Li
Journal:  Biol Trace Elem Res       Date:  2021-11-17       Impact factor: 3.738

2.  Age-dependent decline of copper clearance at the blood-cerebrospinal fluid barrier.

Authors:  Luke L Liu; David Du; Wei Zheng; Yanshu Zhang
Journal:  Neurotoxicology       Date:  2021-10-27       Impact factor: 4.294

3.  Nephroprotective effect of gastrodin against lead-induced oxidative stress and inflammation in mice by the GSH, Trx, Nrf2 antioxidant system, and the HMGB1 pathway.

Authors:  Zhi-Kai Tian; Yu-Jia Zhang; Zhao-Jun Feng; Hong Jiang; Chao Cheng; Jian-Mei Sun; Chan-Min Liu
Journal:  Toxicol Res (Camb)       Date:  2021-03-23       Impact factor: 3.524

Review 4.  Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System.

Authors:  Daniela C Ivan; Sabrina Walthert; Kristina Berve; Jasmin Steudler; Giuseppe Locatelli
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

5.  Pb Induces MCP-1 in the Choroid Plexus.

Authors:  Huiying Gu; Yundan Xu; Nicole Du; Yongqi Yu; Wei Zheng; Yansheng Du
Journal:  Biology (Basel)       Date:  2022-02-15

Review 6.  Amyloid Beta Dynamics in Biological Fluids-Therapeutic Impact.

Authors:  Thomas Gabriel Schreiner; Bogdan Ovidiu Popescu
Journal:  J Clin Med       Date:  2021-12-20       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.